SFX by Ex Libris Inc.

Title:	Questioning the timeline of H1N1 flu vaccination contracts
Source:	Nature [0028-0836] Cohen, D yr:2010

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Holmboe, Eric S S. "Qualitative analysis of mothers' decision-making about vaccines for infants: the importance of trust." Pediatrics 117.5 (2006): 1532-41.
description	2.	Kleinman, A.M. M. "Asian flus in ethnographic and political context: a biosocial approach." Anthropology & medicine 15.1 (2008): 1-5.
description	3.	Wood, D.J. J. "Stopping poliovirus vaccination after eradication: issues and challenges." Bulletin of the World Health Organization 78.3 (2000): 347-357.
description	4.	Inglis, S. "Open debate could slow flu vaccine production." Nature 454.7207 (2008): 939-939.
description	5.	Daems, R. "Anticipating crisis: Towards a pandemic flu vaccination strategy through alignment of public health and industrial policy." Vaccine 23.50 (2005): 5732-5742.
description	6.	Mills, Gordon H J. "Systematically reviewing qualitative studies complements survey design: an exploratory study of barriers to paediatric immunisations." Journal of clinical epidemiology 58.11 (2005): 1101-8.
description	7.	MacDonald, M. "Parents' decisions on MMR vaccination for their children were based on personal experience rather than scientific evidence." Evidence-based nursing 8.2 (2005): 60-60.
description	8.	Bronfin, D.R. R. "Childhood immunization controversies: What are parents asking?" The Ochsner journal 8.3 (2008): 151-156.
description	9.	Hilton, S. "MMR: marginalised, misrepresented and rejected? Autism: a focus group study." Archives of disease in childhood 92.4 (2007): 322-7.
description	10.	Kleinman, A. "Avian and pandemic influenza: A biosocial approach." The journal of infectious diseases 197.Suppl. 1 (2008): -2.
description	11.	Colgrove, J. "Could It Happen Here? Vaccine Risk Controversies And The Specter Of Derailment." Health affairs 24.3: 729-739.
description	12.	Russell, Colin A A. "The global circulation of seasonal influenza A (H3N2) viruses." Science 320.5874 (2008): 340-6.
description	13.	Khan, S. "Learn to listen to parents about flu vaccine.(Your Voice)(Viewpoint essay)." Contemporary pediatrics 25.9 (2008): 18-.
description	14.	"Polio vaccine problems." Bulletin of the World Health Organization 90.8 (2012): 561-.
description	15.	Bhat Schelbert, K. "Barriers to and facilitators of child influenza vaccine - Perspectives from parents, teens, marketing and healthcare professionals." Vaccine 30.14 (2012): 2448-2452.
description	16.	Salvati, Anna L. "Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus." Antimicrobial agents and chemotherapy 48.6 (2004): 2233-2243.
description	17.	Wright, P.F. F. "Strategies for the global eradication of poliomyelitis by the year 2000." The New England journal of medicine 325.25 (1991): 1774-1779.
description	18.	Westrop, GD. "Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine." Journal of virology 63.3 (1989): 1338-1344.
description	19.	Smith, J. "Certification of polio eradication: process and lessons learned." Bulletin of the World Health Organization 82.1 (2004): 24-30.
description	20.	Smith, G J D J. "Emergence and predominance of an H5N1 influenza variant in China." Proceedings of the National Academy of Sciences of the United States of America 103.45 (2006): 16936-41.